Nova review
Membership inside the price
Charges a $99/month membership on top of medication — and then quotes the all-in figure rather than the drug alone.
Our verdict
Nova runs a membership model, which is often a warning sign in this category, and then does the opposite of what the model normally enables. Rather than advertising a low drug price and revealing the membership at checkout, it headlines totals that include the $99/month Nova Care membership: semaglutide "starting at $198/mo", tirzepatide "$210/mo" and its general GLP-1 program "$169/mo". The catch is that the FAQs on those same pages describe a $229/mo semaglutide plan and a $279/mo tirzepatide plan, so the headline may not be what your dose costs. The menu is broad — GLP-1, NAD+ in three routes, sermorelin, oral, sublingual and injectable testosterone, finasteride and dutasteride — across 49 states. Settle the monthly total for your dose in writing before you buy.
Disclosure: Aminoscope is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. Partners are listed first; a commission never changes what we write about a provider. How we make money.
At a glance
- Category
- GLP-1 telehealth
- Access
- GLP-1 program from $169/mo, semaglutide from $198/mo, tirzepatide from $210/mo, each headlined as including the $99/mo membership (its own FAQs cite $229 and $279). 49 states
- Medications
- Compounded semaglutide · Compounded tirzepatide
- Insurance
- Cash-pay, no insurance
- Visit
- Quiz intake / Async intake
- Availability
- 49 states
Partner alternative
Enhance MD
Lab-guided treatment under ongoing physician oversight
Check Enhance MD availability →What it is
A telehealth service selling GLP-1 weight loss, NAD+, sermorelin, testosterone and hair-loss treatment on a membership model, available in 49 states. The membership — Nova Care, $99/month — covers provider consultations, 24/7 messaging, ongoing monitoring and dose adjustments; medication is charged in addition, and the advertised prices are stated to include both. It is a different company from Nova MD, which holds an FDA warning letter; see the FAQ below.
How it works
Asynchronous and questionnaire-led, built around the membership rather than around a per-prescription transaction: consultations, messaging, monitoring and titration are described as covered by the $99 monthly fee, with medication billed on top and the two combined in the quoted price. Nova states 49 states across fourteen pages, publishes per-product detail pages for each item on the menu, and describes medications as third-party tested and compounded by a licensed pharmacy, which it does not name. Its browser-tab title describes it as serving Texas and Florida, which contradicts the 49-state claim.
Pricing transparency
Headlined all-in, but not consistently. Compounded semaglutide is headlined from $198/month and tirzepatide from $210/month, each including the $99/month membership, and a general GLP-1 weight-loss program from $169/month; the semaglutide page's own FAQ, though, describes a $229/month plan and the tirzepatide page's a $279/month plan. NAD+ injectable is headlined from $134/month all-in, though its FAQ lists the medication alone at $105 a month before the membership; sermorelin at $162/month all-in; testosterone cypionate, oral testosterone and sublingual testosterone each "as low as $96/mo"; the hair-restoration program is headlined from $129/month all-in. Nova also publishes a comparison putting its $99 membership against Hims at $149/month and Ro at $145. Confirm the monthly total for your dose before you subscribe.
Branded vs compounded
Compounded semaglutide and tirzepatide, including oral daily-dose and rapid-dissolve formats; NAD+ as injectable, nasal spray and troche; sermorelin, including a rapid-dissolve form; testosterone cypionate, oral and sublingual testosterone; and finasteride and dutasteride for hair loss. On the evidence: GLP-1 outcome data belongs to the branded products, not to compounded copies, and the oral and rapid-dissolve GLP-1 formats have no controlled outcome data of their own. Sermorelin has a real growth-hormone-axis mechanism with thin long-term outcome data. Injectable and intranasal NAD+ have no controlled human outcome trials, with the randomized data sitting on oral NR/NMN precursors. Finasteride and dutasteride are well-evidenced approved drugs for male-pattern hair loss, and Nova states the male-only and teratogenicity warnings for both.
Pros and watch-outs
What we like
- Headlines an all-in monthly figure with the membership included
- Testosterone in three routes — injectable, oral and sublingual — rather than a single default
- NAD+ in three routes; sermorelin in injectable and rapid-dissolve forms
- 49 states stated consistently across the site, rather than a blanket all-50 claim
- Publishes handling and teratogenicity warnings on the hair-loss products
Watch-outs
- A $99/month membership is unavoidable, so short courses carry a large fixed overhead
- Its headline GLP-1 prices disagree with the figures in its own FAQs ($198 against $229 for semaglutide)
- The compounding pharmacy is not named
- The browser-tab title says "Texas & Florida", which contradicts its own 49-state claim
- Name collision with Nova MD, an unrelated company holding an FDA warning letter
Best for
Readers who want consultations, messaging and titration bundled into one predictable monthly figure, and who intend to stay on treatment long enough for the membership to amortize.
Who should look elsewhere
Anyone trying a GLP-1 for a month or two, since $99 of every month is fixed regardless of medication, or anyone in the one state Nova does not cover.
The evidence behind what Nova prescribes
We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.
- What the semaglutide weight-loss trials actually showed
STEP 1, STEP 4, and SELECT — the efficacy, the rebound, and the cardiovascular signal, read straight from the primary literature.
- Sermorelin benefits: does it work? What the trials show
A real GHRH drug, read against the anti-aging pitch: an approved growth-hormone-releasing analog with a pediatric track record, and a longevity case built more on biomarkers than outcomes.
- NAD+ injections: benefits, side effects, cost and what the evidence says
Subcutaneous NAD+ is sold as a cheaper, at-home alternative to the IV drip, through “near me” clinics or telehealth shipped to your door. It’s compounded, not FDA-approved, and has no outcome trials; oral NR/NMN precursors are the route with the human data.
- TRT: what testosterone therapy is actually proven to do
An FDA-approved therapy for diagnosed hypogonadism — with real but moderate benefits (sexual function, mood; not vitality), cardiovascular non-inferiority in TRAVERSE, and a real fertility trade-off.
How Nova compares
A few alternatives worth a look, depending on what you’re optimizing for.
- MEDGm
Readers who want compounded and brand-name GLP-1 routes presented side by side
See MEDGm → Willow
Buyers who want every dose priced and the pharmacies named, and will pay more for it
See Willow →
MondaeBuyers who want a low, honest month-to-month price with the compounding source named
See Mondae →
More GLP-1 telehealth reviews: Care ClinicsCurexEffectyElara Health and WellnessEnara HealthEOS Health
Access & cost
How we assessed this. This review reflects Aminoscope’s own read of Nova’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- Is Nova the same company as Nova MD?
- No, and it matters before you read anything else about either. Nova MD holds FDA warning letter #716695, issued 9 September 2025 over a compounded-semaglutide claim. The letter is addressed to Nova MD and names only Nova MD's website. Nova, the company reviewed here, runs a different website, registered at a different time, with a different product model, so the letter does not apply to it. Make sure the site you sign up on is the one you mean.
- What does the $99 monthly membership actually cover?
- Nova states it covers provider consultations, 24/7 messaging, ongoing monitoring and dose adjustments — the clinical service around the prescription rather than the drug itself. The medication is billed separately, and the prices Nova advertises include both. So a semaglutide plan is $99 of membership plus the medication, which the site headlines at "$198/mo" in total while its own FAQ describes $229/mo. That structure is worth understanding because the membership is fixed: if you stop treatment but keep the membership, or run a short course, the $99 is dead weight.
- Is quoting the membership inside the price unusual?
- Yes, and it is why Nova's pricing reads as more honest than most membership models. Collective advertises "$59/month" for semaglutide while requiring a $199 annual membership stated only in its FAQ. MEDGm quotes "$99 membership + cost" without ever showing the cost. Nova headlines $198 with the membership already included, which makes it directly comparable to a flat-rate provider like Mondae at $87 — though its own FAQ cites $229 for the same plan, so confirm which figure you will pay.
- How many states does Nova serve?
- Forty-nine, stated consistently across fourteen of its pages. Its browser-tab title reads "Personalized Telehealth & Wellness in Texas & Florida", which contradicts that. The 49-state figure is the one repeated throughout the site, but confirm your own state during the questionnaire.
- Why do Nova's prices differ between pages?
- Its headline figures include the $99 membership — semaglutide "starting at $198/mo", tirzepatide "$210/mo" — but the FAQs on the same pages describe $229 and $279 plans, and testosterone is shown "as low as $96/mo", below the membership alone. The figures appear to mix different doses or offers across pages, so ask for the monthly total for your dose in writing before you subscribe.
- Is Nova legit?
- Nova is a GLP-1 telehealth service you reach through an online questionnaire and an online intake a clinician reviews. The medications it names are Compounded semaglutide and Compounded tirzepatide. What it publishes up front: GLP-1 program from $169/mo, semaglutide from $198/mo, tirzepatide from $210/mo, each headlined as including the $99/mo membership (its own FAQs cite $229 and $279). 49 states. It is cash-pay and states it does not bill insurance. Those are the provider's own published claims rather than checks we could run ourselves, so get the ones that matter to you confirmed in writing before you pay.
- Is Nova expensive compared with other GLP-1 telehealth providers?
- Nova publishes a starting figure of $198/mo. Across the 112 GLP-1 telehealth providers we review that publish a single monthly figure, those run $49 to $399 with a median of $179, which puts Nova above the median. The other 173 GLP-1 telehealth providers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.